Clinical Trial Update: Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose naltrexone for central neuropathic pain in people with spinal cord injury is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Naltrexone (low-dose) (naltrexone)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Central Neuropathic Pain, Spinal Cord Injury | Phase 2 | Status: RECRUITING